The Company has granted restricted stock and restricted stock units (collectively, “Restricted Stock”), as well as unrestricted stock and stock options, to employees and directors under the 2021 Equity Incentive Plan. Upon vesting of Restricted Stock, shares of common stock are released to the grantee.

As of June 30, 2026, the Company had approximately 2.1 million shares of service-based Restricted Stock and approximately 134 thousand shares of performance-based Restricted Stock outstanding. The Company also had approximately 24.9 million stock options outstanding, of which 23.4 million stock options were exercisable as of June 30, 2026.

For the three and six months ended June 30, 2026 and 2025, the Company recognized share-based compensation expense related to all share-based awards as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Cost of revenues	$	31	$	62	$	72	$	124
General and administrative expenses	703		566		1,526		1,003
Research and development expenses	78		156		184		306
Selling and marketing expenses	30		62		68		116
Total	$	842	$	846	$	1,850	$	1,549